EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multicellular model of neuroblastoma proposes unconventional therapy based on multiple roles of p53

Kenneth Y Wertheim iD, Robert Chisholm iD, Paul Richmond iD, Dawn Walker iD

PLOS Computational Biology · 23.12.2024 · 20 (12) · e1012648

DOI: 10.1371/journal.pcbi.1012648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 23.12.2024. Verfasst von Kenneth Y Wertheim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Insigneo Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom. Hauptthemen laut MEDLINE: Neuroblastoma, Tumor Suppressor Protein p53, Models, Biological, Tumor Microenvironment. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroblastoma is the most common extra-cranial solid tumour in children. Over half of all high-risk cases are expected to succumb to the disease even after chemotherapy, surgery, and immunotherapy. Although the importance of MYCN amplification in this disease is indisputable, the mechanistic details remain enigmatic. Here, we present a multicellular model of neuroblastoma comprising a continuous automaton, discrete cell agents, and a centre-based mechanical model, as well as the simulation results we obtained with it. The continuous automaton represents the tumour microenvironment as a grid-like structure, where each voxel is associated with continuous variables such as the oxygen level therein. Each discrete cell agent is defined by several attributes, including its cell cycle position, mutations, gene expression pattern, and more with behaviours such as cell cycling and cell death being stochastically dependent on these attributes. The centre-based mechanical model represents the properties of these agents as physical objects, describing how they repel each other as soft spheres. By implementing a stochastic simulation algorithm on modern GPUs, we simulated the dynamics of over one million neuroblastoma cells over a period of months. Specifically, we set up 1200 heterogeneous tumours and tracked the MYCN -amplified clone’s dynamics in each, revealed the conditions that favour its growth, and tested its responses to 5000 drug combinations. Our results are in agreement with those reported in the literature and add new insights into how the MYCN -amplified clone’s reproductive advantage in a tumour, its gene expression profile, the tumour’s other clones (with different mutations), and the tumour’s microenvironment are inter-related. Based on the results, we formulated a hypothesis, which argues that there are two distinct populations of neuroblastoma cells in the tumour; the p53 protein is pro-survival in one and pro-apoptosis in the other. It follows that alternating between inhibiting MDM2 to restore p53 activity and inhibiting ARF to attenuate p53 activity is a promising, if unorthodox, therapeutic strategy. The multicellular model has the advantages of modularity, high resolution, and scalability, making it a potential foundation for creating digital twins of neuroblastoma patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaTumor Suppressor Protein p53Models, BiologicalTumor MicroenvironmentHumansComputer SimulationComputational BiologyN-Myc Proto-Oncogene ProteinAlgorithms

Substanzen

Tumor Suppressor Protein p53N-Myc Proto-Oncogene ProteinTP53 protein, human

Autor:innen und Institutionen

  • Insigneo Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
  • School of Computer Science, University of Sheffield, Sheffield, United Kingdom.
  • Centre of Excellence for Data Science, Artificial Intelligence, and Modelling, University of Hull, Kingston upon Hull, United Kingdom.
  • School of Computer Science, University of Hull, Kingston upon Hull, United Kingdom.

ORCID-Profile: Kenneth Y Wertheim, Robert Chisholm, Paul Richmond, Dawn Walker

Förderung

  • Horizon 2020 Framework Programme

Zitieren

APA

Wertheim, K. Y., Chisholm, R., Richmond, P., & Walker, D. (2024). Multicellular model of neuroblastoma proposes unconventional therapy based on multiple roles of p53. PLOS Computational Biology, 20(12), e1012648. https://doi.org/10.1371/journal.pcbi.1012648

Vancouver

Wertheim KY, Chisholm R, Richmond P, Walker D. Multicellular model of neuroblastoma proposes unconventional therapy based on multiple roles of p53. PLOS Computational Biology. 2024;20(12):e1012648. doi:10.1371/journal.pcbi.1012648

BibTeX
@article{Wertheim2024,
  author = {Wertheim, Kenneth Y and Chisholm, Robert and Richmond, Paul and Walker, Dawn},
  title = {Multicellular model of neuroblastoma proposes unconventional therapy based on multiple roles of p53},
  journal = {PLOS Computational Biology},
  year = {2024},
  volume = {20},
  number = {12},
  pages = {e1012648},
  doi = {10.1371/journal.pcbi.1012648}
}
Kostenlos starten →